Gairdner Science Week 2025
October 22:INTERNATIONAL SYMPOSIUM
Share this event
This year’s International Symposium celebrates the pioneering work of Drs. Michael J. Welsh and Paul Negulescu, recipients of the 2025 Canada Gairdner International Award. Their research into the molecular mechanisms of cystic fibrosis has led to the development of breakthrough therapies that have profoundly changed patient outcomes. Join a global lineup of leading scientists as we explore new therapeutic innovations and the power of curiosity-driven research to change lives.
Can't attend in person? Join us via livestream at https://bit.ly/GSW_2025_Watch_Live.
Register here
Schedule
| 9:00 am | Introductory Remarks |
| Janet Rossant, President & Scientific Director, Gairdner Foundation | |
| 9:05 am | Identification of the Cystic Fibrosis Gene |
| Dr. Lap-Chee Tsui, PhD, Senior Scientist Emeritus, Research Institute, The Hospital for Sick Children, Toronto; Emeritus University Professor, University of Toronto | |
| 9:35 am | Pursuing CF |
| Michael Welsh, MD, Roy J. Carver Professor of Internal Medicine and Molecular Physiology and Biophysics; Director, Pappajohn Biomedical Institute; Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA | |
| 10:10 am | The Journey to Discover CFTR Modulators for the Treatment of Cystic Fibrosis |
| Dr. Paul Negulescu, PhD, Senior Vice President, Vertex Pharmaceuticals, San Diego, CA, USA | |
| The Chemistry Behind CFTR Modulators | |
| Dr. Sabine Hadida, PhD, Senior Vice President, Vertex Pharmaceuticals, San Diego, CA, USA | |
| 10:55 am | Early Career Investigator Presentation Microbe-Interfacing Nanomaterials to Study and Treat Bacterial Biofilm Infections |
| Dr. Joel Finbloom, PhD, Assistant Professor, Faculty of Pharmaceutical Sciences, University of British Columbia | |
| 11:10 am | Health Break |
| 11:30 am | Antibody Approaches to Overcome Viral Diversity for Global Health |
| Dr. Jean-Philippe Julien, PhD, Canada Research Chair in Structural Immunology; Senior Scientist, Program in Molecular Medicine, The Hospital for Sick Children Research Institute; Associate Professor, Departments of Biochemistry and Immunology, University of Toronto; Toronto, ON, Canada | |
| 12:00 pm | Turning Genes into Medicines: Successes and Limitations of In Vivo Gene Therapy |
| Dr. Katherine High, MD, Visiting Professor, Allen and Frances Adler Laboratory of Blood and Vascular Biology, Rockefeller University; Emeritus Professor, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA | |
| 12:30 pm | Exploration of Biological Diversity |
| Dr. Feng Zhang, PhD, Investigator, Howard Hughes Medical Institute, James and Patricia Poitras Professor in Neuroscience, MIT; Core Institute Member, Broad Institute; Cambridge, MA, USA | |
| 1:00 pm | Closing Remarks |
| Janet Rossant, President & Scientific Director, Gairdner Foundation |
Location
MaRS Auditorium, Lower Concourse, 101 College Street, Toronto, ON